Is Axe Still Selling? A Boots-on-the-Ground Check of the Brand's Comeback

Axe was once a teenage boy's essential. In the early 2000s, its body spray was a near-universal staple, and by the 2010s, Unilever was pulling in nearly half a billion dollars in U.S. sales for the brand alone. But the story took a turn. As the brand expanded into body wash and hair care, the advertising dollars got diluted, and the messaging shifted away from its core product. By 2017, U.S. sales had fallen by an estimated $150 million from their peak. The brand, once synonymous with a specific locker room energy, needed a reboot.

Now, Unilever is on a mission to re-find its edge. The plan is a two-pronged attack. First, it launched a fine fragrance collection in 2023, aiming to elevate the product experience and shed the "middle school locker stigma." Second, it's leaning hard into Gen Z humor, recognizing that comedy is a serious business for grabbing attention. The new ads, created with agency LOLA MullenLowe, amp up the absurdity, with one basketball ad getting 33 million views organically and a 300% sales lift in the UK.

This revival is part of a broader push within Unilever. In its first quarter of 2025, the company's overall underlying sales grew 3%, with its Beauty & Wellbeing segment leading the charge at 7.4% growth. That segment's strength, powered by brands like Dove and core personal care, provided the runway for Axe's rebranding efforts. The question for investors is whether this is a real consumer comeback or just clever marketing. The fine fragrance collection and viral comedy campaigns are bold moves, but the real test is whether people are still buying the spray. The numbers show growth is happening, but the smell test is the only one that matters.

Kick the Tires: Measuring Real Demand vs. Marketing Hype

The numbers Unilever reports are a start, but they don't tell the whole story. The real test is whether people are actually buying the spray, not just watching the ads. The company's Q1 results show a mixed picture. While the overall group saw a slight sales dip, its Beauty & Wellbeing segment powered ahead with 7.4% underlying sales growth. That growth was driven by 5.6% volume growth, which is the key metric. It suggests genuine demand is returning, not just price increases. This strength in core personal care, where brands like Dove and Rexona also performed well, provided the runway for Axe's rebranding. The fine fragrance collection, launched in 2023, is a central part of this story. The brand claims it has helped drive growth across all our markets around the world. That's a broad claim, but the evidence points to specific, tangible results. Campaigns have gone viral, with one basketball ad getting 33 million views organically and a 300% uplift in UK sales. Limited editions like the catnip-scented variant have built customer waiting lists. These are the kinds of consumer reactions that signal real engagement, not just marketing noise.

Yet, the growth isn't universal. The same Q1 report shows prestige beauty saw a decline in sales, attributed to market softness. This hints that the recovery is concentrated in mass-market, value-driven categories like deodorants and body washes. For Axe, that's the right place to be. The brand's revival is happening within a segment that's already proven its resilience. The challenge now is to see if this momentum can spill over into other areas or if it remains a story of a single, well-executed comeback within a broader, still-struggling category.

The Competitive Landscape: Can Axe Win Without P&G's Pampers?

The real test for Axe isn't just its own comeback-it's how it fares in a tough market where even giants are struggling. Look at Procter & Gamble, a direct competitor in the personal care space. In its latest quarter, P&G's overall organic sales were flat, a sign of a broader consumer slowdown. More telling, its Baby Care and Feminine Care units saw low single-digit organic sales declines. That's a clear signal that demand softness is hitting core staples, not just niche categories. For Axe, which competes in mass-market deodorants and body washes, this sets the stage.

The global deodorant market itself is projected to grow, but competition is fierce. New product types and categories are emerging, making it harder for any one brand to dominate. In this environment, Axe's revival is happening against a backdrop of industry headwinds. The fact that Unilever's Beauty & Wellbeing segment powered ahead with 7.4% underlying sales growth in Q1 is a strong relative performance. It shows the company is executing well, even as the broader category faces pressure.

The key question is whether Axe's momentum can hold. Its growth is concentrated in the mass-market categories where P&G is also seeing volume declines. This suggests Axe is gaining share from rivals, not just riding a market upswing. The brand's focus on Gen Z humor and its fine fragrance collection appear to be resonating in a way that's pulling customers away from more traditional offerings. In other words, Axe is winning without needing P&G's Pampers to be strong. It's a sign of a brand that's successfully re-earned its place in the consumer's daily routine, even as the overall market gets tougher.

Catalysts and Risks: What to Watch for the Next Quarter

The turnaround thesis for Axe hinges on a simple question: is this a lasting revival or a clever marketing event? The next earnings report will be the first real test. Investors should watch for Axe's specific contribution to Unilever's Beauty & Wellbeing segment growth. The segment's 7.4% underlying sales growth in Q1 was powered by a 5.6% volume growth, with core personal care brands like Dove and Rexona also performing well. The key will be to see if Axe's share of that growth is accelerating or if it's being pulled along by the broader category. If the brand's volume gains are lagging, it could signal the revival is more about price or mix than genuine consumer demand.

Another near-term signal is the performance of the fine fragrance collection. The brand claims it has helped drive growth across all our markets around the world. The viral social campaigns, like the one that generated 33 million views organically and a 300% uplift in UK sales, are impressive. But the real test is whether these one-off hits translate into sustained volume increases for the core spray line. Monitor social media sentiment and sales data for the collection's limited editions. If they build lasting brand loyalty and drive repeat purchases, that's a strong sign of a durable turnaround. If the buzz fades quickly, it confirms the risk that the revival is a short-term event.

The biggest risk is that Axe's comeback is a one-quarter wonder. The brand's earlier decline was steep, with U.S. sales falling by an estimated $150 million between 2012 and 2017. That's a massive hole to fill. The current momentum needs to be more than just a series of funny ads and limited editions. It needs to show up in the volume numbers quarter after quarter. If the next report shows the Beauty & Wellbeing segment's growth slowing or the fine fragrance collection's sales plateauing, it would be a red flag. The brand's success in gaining share from rivals like P&G, which is seeing volume declines, is a positive sign. But that share gain must hold. For now, the evidence points to a brand that's found a new groove. The next quarter will tell us if it's a sprint or a marathon.